LMAT R&D Expenses
Lemaitre Vascular Inc · R&D Expenses
LMAT R&D Expenses
Latest reported$15.41Mperiod ending
LMAT TTM R&D Expenses ($0.00 → $15.41M)
TTM R&D Expenses
High-resolution chart · PNG
LMAT r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 15,410,000 | |
| 14,104,000 | |
| 14,139,000 | |
| 14,224,000 | |
| 14,910,000 | |
| 15,653,000 | |
| 15,650,000 | |
| 16,383,000 | |
| 16,951,000 | |
| 17,183,000 | |
| 16,966,000 | |
| 16,169,000 | |
| 15,407,000 | |
| 14,237,000 | |
| 13,294,000 | |
| 13,197,000 | |
| 12,583,000 | |
| 11,889,000 | |
| 11,801,000 | |
| 11,213,000 | |
| 10,463,000 | |
| 9,950,000 | |
| 10,100,000 | |
| 9,730,000 | |
| 9,913,000 | |
| 10,030,000 | |
| 9,276,000 | |
| 9,124,000 | |
| 8,880,000 | |
| 8,612,000 | |
| 8,197,000 | |
| 7,433,000 | |
| 7,157,000 | |
| 6,803,000 | |
| 6,636,000 | |
| 6,574,000 | |
| 6,352,000 | |
| 6,352,000 | |
| 6,140,000 | |
| 6,194,000 | |
| 6,076,000 | |
| 5,773,000 | |
| 5,479,000 | |
| 4,985,000 | |
| 4,673,000 | |
| 4,479,000 | |
| 4,671,000 | |
| 4,992,000 | |
| 5,183,000 | |
| 5,314,000 | |
| 5,243,000 | |
| 5,402,000 | |
| 5,363,000 | |
| 5,230,000 | |
| 5,092,000 | |
| 4,670,000 | |
| 4,383,000 | |
| 4,288,000 | |
| 4,425,000 | |
| 4,761,000 | |
| 4,922,000 | |
| 5,220,000 | |
| 5,488,000 | |
| 5,729,000 | |
| 6,042,000 | |
| 6,139,000 | |
| 5,910,000 | |
| 5,495,000 | |
| 5,250,000 | |
| 5,289,000 | |
| 5,328,000 | |
| 5,202,000 | |
| 5,143,000 | |
| 4,787,000 | |
| 4,591,000 | |
| 4,131,000 | |
| 3,792,000 | |
| 3,660,000 | |
| 3,301,000 | |
| 2,586,000 | |
| 1,781,000 | |
| 795,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |